---
figid: PMC5342378__oncotarget-07-54744-g008
figtitle: PAX3 is a novel tumor suppressor by regulating the activities of major signaling
  pathways and transcription factor FOXO3a in thyroid cancer
organisms:
- NA
pmcid: PMC5342378
filename: oncotarget-07-54744-g008.jpg
figlink: /pmc/articles/PMC5342378/figure/F8/
number: F8
caption: PAX3 increases the expression of FOXO3a at transcriptional levels through
  up-regulating ZIC1 expression or other unknown mechanisms. Meanwhile, PAX3 inhibits
  phosphorylation of FOXO3a, nuclear-cytoplasmic translocation and proteasome degradation
  through blocking the activity of PI3K/Akt and MAPK pathways, subsequently enhancing
  FOXO3a transcriptional activity in thyroid cancer cells. Downstream targets of FOXO3a
  exert tumor suppressive function through induction of cell cycle arrest and apoptosis,
  and inhibition of tumor metastasis. Moreover, PAX3 can also regulate cell cycle
  through modulating p16/Rb/E2F pathway via inhibition of major signaling pathways
  such as MAPK/Erk cascade.
papertitle: PAX3 is a novel tumor suppressor by regulating the activities of major
  signaling pathways and transcription factor FOXO3a in thyroid cancer.
reftext: Wei Liu, et al. Oncotarget. 2016 Aug 23;7(34):54744-54757.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9661514
figid_alias: PMC5342378__F8
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5342378__F8
ndex: 10718e5d-ded1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5342378__oncotarget-07-54744-g008.html
  '@type': Dataset
  description: PAX3 increases the expression of FOXO3a at transcriptional levels through
    up-regulating ZIC1 expression or other unknown mechanisms. Meanwhile, PAX3 inhibits
    phosphorylation of FOXO3a, nuclear-cytoplasmic translocation and proteasome degradation
    through blocking the activity of PI3K/Akt and MAPK pathways, subsequently enhancing
    FOXO3a transcriptional activity in thyroid cancer cells. Downstream targets of
    FOXO3a exert tumor suppressive function through induction of cell cycle arrest
    and apoptosis, and inhibition of tumor metastasis. Moreover, PAX3 can also regulate
    cell cycle through modulating p16/Rb/E2F pathway via inhibition of major signaling
    pathways such as MAPK/Erk cascade.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - MAPK1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - PAX3
  - AKT1
  - AKT2
  - AKT3
  - ZIC1
  - FOXO3
  - TWIST1
  - SNAI1
  - SNAI2
  - GADD45A
  - TNFSF10
  - CCND1
  - CDK6
  - CDK4
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK5
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - BCL2L11
  - IFI27
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - RBL2
  - NOLC1
  - RAB3GAP1
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CDH2
  - CDH1
  - FZR1
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - CDKN2A
  - H3P10
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - Cancer
---
